Angiolutions was founded by two seasoned and award-winning physicians, Dr. Isabel Schellinger and Dr. Uwe Raaz, leveraging their extensive expertise in both basic research and vascular medicine to tackle the large unmet need for small abdominal aortic aneurysm (AAA) therapy and thereby revolutionize the way AAAs are managed. At Angiolutions, we take advantage of a condensed interdisciplinary expertise in basic research, clinical medicine, business strategy, vascular interventions, biomechanics, and engineering. This sets us apart from traditional Medtech companies and enables fresh perspective on medical problems giving rise to highly ingenious devices in cardiovascular medicine.